Rongen Roelof 4
4 · Matinas BioPharma Holdings, Inc. · Filed Sep 11, 2017
Insider Transaction Report
Form 4
Rongen Roelof
DirectorChief Executive Officer
Transactions
- Purchase
Common Stock
2017-09-08$1.36/sh+5,000$6,800→ 3,539,416 total
4 · Matinas BioPharma Holdings, Inc. · Filed Sep 11, 2017
Common Stock